Article
Clonal evolution driven by superdriver mutations.
BMC evolutionary biology - 20 Jul 2020
Grossmann Patrick, Cristea Simona, Beerenwinkel Niko
Abstract excerpt
BACKGROUND: Tumors are widely recognized to progress through clonal evolution by sequentially acquiring selectively advantageous genetic alterations that significantly contribute to tumorigenesis and thus are termned drivers. Some cancer drivers, such as TP53 point mutation or EGFR copy number gain, provide exceptional fitness gains, which, in time, can be sufficient to trigger the onset of cancer with little or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
